TP53 and neoplasm: For example, in HPV-16-positive and HPV-18-positive CC cell lines, the E6 protein down-regulates the tumor suppressor miR-34a [78] and miR-23b [79] by inhibiting p53, thereby leading to cell cycle progression and increased expression of urokinase-type plasminogen activator (uPA), respectively.